Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0220
-0.0010 (-4.35%)
Jan 30, 2026, 1:25 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 81.52 million as of January 29, 2026. Its market cap has increased by 16.78% in one year.
Market Cap
81.52M
Enterprise Value
50.48M
Revenue
12.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 81.52M, a decrease of -19.56%. That is a compound annual growth rate of -5.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 81.52M | -8.00% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 118.87M |
| Imugene | 113.52M |
| Island Pharmaceuticals | 113.00M |
| LTR Pharma | 106.26M |
| Arovella Therapeutics | 102.10M |
| Prescient Therapeutics | 88.33M |
| Alterity Therapeutics | 87.00M |
| EZZ Life Science Holdings | 86.09M |